antibodies

Impaired Tolerance of Self-Tissues Leads to Autoantibodies Against IFN-I

Autoantibodies against type I interferons (IFN-I) increase susceptibility to severe infections

Rejuvenation of the Immune System: A New Method to Combat Age-Related Immunity Decline

Altering Stem Cell Balance to Combat Aging of the Immune System

Autoantibodies to Interferons Are Not Associated with Chronic Fatigue after COVID-19

Only 1.6% of patients with post-COVID syndrome had autoantibodies to IFN-β

Autoantibodies to Type I Interferons in COVID-19 Patients

Autoantibodies to tissues, immune cells and interferons complicate the course of COVID-19

Antibody-Free Protection: The Effectiveness of COVID-19 Vaccination in Patients with B-Cell Deficiency

Enhanced T-cell responses with B-cell deficiency reduce the risk of severe COVID-19 by 5-fold

Protection Against Omicron: New Vaccines on the Horizon

The World Health Organization has recommended a monovalent vaccine based on the Kraken strain, a subvariant of Omicron

Coronavirus Pyrola: Do Vaccines and Previous Infection Protect Against Other Strains?

Mutations in the Spike Protein Help Pyrola Evade Immune Protection

Indigenous Peoples in Australia More Severely Ill COVID-19

The reason for the weak antibody response is chronic diseases

IgM Antibodies Protect Against Delta and Omicron Strains

IgM antibodies derived from memory B cells neutralize a wide range of coronavirus strains

Post-Vaccination and Natural COVID-19 Antibodies: Which Protect Better?

S-protein in a closed state as the basis of future vaccines

Common Cold Immunity Protects Children From COVID-19

Protein S2 – a promising basis for future coronavirus vaccines

How Long Do Antibodies Persist After COVID-19

After natural SARS-CoV-2, protection against reinfection persists for about two years

What Level of Neutralizing Antibodies Protects Against COVID-19

Antibody titers predict the protective efficacy of vaccines

COVID-19 Symptoms Depend on The Infecting Dose

SARS-CoV-2 dose affects seroconversion and fever

The dominant role of IgA antibodies in the early stage of COVID-19

Most of the IgA is in the mucous membranes, the entrance gate of the coronavirus

Immunological memory for SARS-CoV-2. Five components of the immune response

How coronavirus immunity is formed and how long it lasts. Is immune memory produced and stored for how long in mild and asymptomatic COVID-19

Natural and Post-Vaccination COVID-19 Antibodies: What Is Most Important

Protective level of antibodies to SARS-CoV-2: when it is produced, what it depends on, and how much is stored

Herd immunity to COVID-19

How do cross-reactive memory T cells affect herd immunity to SARS-CoV-2

A way to successful vaccination

Зачем нужны вакцины. Как они работают. Что повышает их эффективность

Russian microbiologists have isolated antibodies that block the reproduction of SARS-CoV-2

Single sorting of B-lymphocytes will increase vaccines safety and make COVID-19 treatment more effective.